Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by DavidKingCanadaon Aug 08, 2021 6:45pm
107 Views
Post# 33670028

RE:RE:RE:RE:Further Dilution of Shares

RE:RE:RE:RE:Further Dilution of Shares

GT, I understand where you are coming from. I never sold any of my Shares and have zero plans to ever Sell. 

Let's be realistic for a moment, PMN is a small cap Canadian Company. Before PMN breaks a $1.00 it will be Bought out by much larger International Corporations with BILLIONS of Dollars in Cash. 

There is Zero chance a Small Cap
UNKNOWN Company will ever Hold the Torch and Run with it. 

Most of my Portfolio is in REAL Canadian Long Term Holds like Enbridge and Canadian Banks.

I Invest not to gamble but for Long Term Growth. I stumbled upon PMN at 0.10 and have already doubled $40,000 to $90,000. I am NOT Selling. 

Good luck to all and let's get this Company going! 

<< Previous
Bullboard Posts
Next >>